Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis

Published:2021-09-01 Issue:1 Volume:45 Page:13-24
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Wilson Nathaniel R.,Lockhart Jonathan R.,Garcia-Perdomo Herney A.,Oo Thein H.,Rojas-Hernandez Cristhiam M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference97 articles.

1. The intriguing history of cancer immunotherapy;Dobosz;Front Immunol,2019

2. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms;Parry;Mol Cell Biol,2005

3. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer;Finn;Ann Oncol,2012

4. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study;Delanoy;Lancet Haematol,2019

5. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline;Brahmer;J Clin Oncol,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and challenges of anti-PD1 in MSI-H mCRC: a case report on concurrent infections and ir-AIHA;Frontiers in Oncology;2024-08-13

2. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer;Journal of Nippon Medical School;2024-06-25

3. Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report;Frontiers in Immunology;2024-03-20

4. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

5. Checkpoint inhibitors;Hematology;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3